Author name: Ananta Kar

Ananta is wrapping up her postgraduate studies in Comparative Literature whilst juggling a solid two-year writing career. She cut her teeth as a sports journalist before discovering her true passion: India's exploding gaming scene. These days, she's obsessed with how gaming culture is reshaping the country, and her academic research chops bring unexpected depth to every piece. Whether dissecting esports trends or exploring biologics in India, renewable energy, electric Vehicles & Smart Transportation topics, Ananta writes with the curiosity of a researcher and the energy of someone who genuinely loves what they do.

Avatar photo

India to Remain Global Wind Power Export Hub: Turbines Made in India, Powering the World

Whilst China dominates solar panel manufacturing and Europe leads offshore wind innovation, India has quietly secured its position as the world’s indispensable wind power component supplier. The country doesn’t just manufacture turbines for domestic installations—it exports nacelles, blades, towers, and gearboxes that power wind farms from Europe to Southeast Asia. By 2025, India produces roughly […]

India to Remain Global Wind Power Export Hub: Turbines Made in India, Powering the World Read More »

India’s Biologics Industry Goes Green: When Profit Meets Planetary Responsibility in Drug Manufacturing

India’s biologics manufacturers just discovered something remarkable: going green actually saves money while winning international contracts simultaneously. Companies like Biocon, Sun Pharma, and Dr. Reddy’s aren’t embracing sustainable biomanufacturing because of environmental activism—they’re doing it because European and North American buyers now demand demonstrable green credentials for procurement contracts. India exported over $7 billion worth

India’s Biologics Industry Goes Green: When Profit Meets Planetary Responsibility in Drug Manufacturing Read More »

Indian Pharma’s AI Gamble: How Algorithms Are Reshaping Drug Discovery and Clinical Trials

India’s pharmaceutical industry has just placed a massive bet on artificial intelligence, and there’s no turning back now. Companies like Biocon, Dr. Reddy’s, and Cipla aren’t just experimenting with AI anymore—they’re integrating machine learning algorithms directly into drug discovery pipelines, clinical trial designs, and manufacturing processes. This shift from experimental pilots to strategic platforms represents

Indian Pharma’s AI Gamble: How Algorithms Are Reshaping Drug Discovery and Clinical Trials Read More »

India’s $300 Billion Bioeconomy Vision: Turning Biology Into Business by 2030

Ten years ago, India’s bioeconomy barely registered at $10 billion—a modest figure reflecting limited biotechnology commercialization and fragmented industry support. Fast forward to 2024, and that figure has exploded to $165.7 billion, representing one of the fastest biotechnology sector expansions globally. Yet India isn’t stopping there. The government has set an audacious target: building a

India’s $300 Billion Bioeconomy Vision: Turning Biology Into Business by 2030 Read More »

Designing for Diversity: How Indian Games Can Capture the Country’s Many Voices

Most countries deal with one or two dominant languages when designing games. India confronts 22 officially recognized languages and over 1,600 dialects. Most gaming markets feature relatively homogeneous cultural preferences. India spans dozens of distinct regional cultures, each with unique festivals, folklore, and aesthetic traditions. This extraordinary diversity represents both India’s greatest challenge and its

Designing for Diversity: How Indian Games Can Capture the Country’s Many Voices Read More »

From Passive Viewers to Active Participants: How Digital Platforms Transformed Entertainment

Remember when entertainment meant sitting quietly in front of a television, consuming whatever broadcasters decided to air? Those days are definitively over. Today’s audiences don’t just watch—they choose, create, interact, and shape the content they consume. The transformation from passive viewing to active participation represents perhaps the most significant shift in entertainment history, fundamentally changing

From Passive Viewers to Active Participants: How Digital Platforms Transformed Entertainment Read More »

India’s Indie Game Developers Are Building the Future in Bedrooms and Basements—Not Boardrooms

Whilst India’s major gaming studios chase mobile monetisation and licensed franchises, a quieter revolution unfolds in bedrooms, co-working spaces, and tiny studios across the country. Indie game developers—operating outside large corporate structures with minimal budgets and maximal passion—are building games the world hasn’t seen before. Titles like Raji: An Ancient Epic and Mumbai Gullies don’t

India’s Indie Game Developers Are Building the Future in Bedrooms and Basements—Not Boardrooms Read More »

Consumer Watchdog Crashes Supreme Court Gaming Battle: ABGP Says Ban Protects Lives, Not Just Business

The Supreme Court’s November 4th hearing on India’s gaming ban just got more complicated. The Akhil Bhartiya Grahak Panchayat (ABGP), a prominent consumer protection body, formally requested intervention in the case challenging the Promotion and Regulation of Online Gaming Act, 2025. While gaming companies argue that the blanket ban violates constitutional rights to conduct business,

Consumer Watchdog Crashes Supreme Court Gaming Battle: ABGP Says Ban Protects Lives, Not Just Business Read More »

GDAI Launches Policy Secretariat: India’s Gaming Industry Gets Its Voice

India’s gaming industry has exploded over the past five years, riding waves of affordable smartphones, faster internet, and millions of enthusiastic players. Yet despite this momentum, developers face persistent roadblocks—ambiguous regulations, unclear intellectual property protections, and a chronic shortage of skilled talent. The Gaming and Developers Association of India has decided it’s time to tackle

GDAI Launches Policy Secretariat: India’s Gaming Industry Gets Its Voice Read More »

India Unveils Formal Drug Approval Rules: A Regulatory Revolution Begins

India’s pharmaceutical industry has operated for decades under a cloud of regulatory uncertainty. Approval timelines were unpredictable, expert panel selections remained opaque, and companies often complained about inconsistent decisions that cost time and money. That era is ending. The Central Drugs Standard Control Organisation has unveiled India’s first comprehensive formal rules governing drug approval panels,

India Unveils Formal Drug Approval Rules: A Regulatory Revolution Begins Read More »

Scroll to Top